These data suggest that FAK inhibition alone may activate pro-survival Erk1⁄2 signaling and attenuate apoptotic signaling, but combining FAK and Hsp90 inhibition reduces Erk1⁄2 activation, resulting in further cancer cell death. The gene discussed is PTK2; the disease is cancer.